Showing results (1-10 of 189) with videos related to
Sort By:
Pageof 19
Pharmacology & Therapeutics|November 4, 2024
Lipoprotection in cardiovascular diseasesMarcel Benkhoff, Amin PolzinPharmacology & Therapeutics|May 25, 2020
Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapyLisa Dannenberg, Dorothee Zikeli, Marcel Benkhoff, et al.Journal of Cellular and Molecular Medicine|November 3, 2025
Sphingosine-1-Phosphate Lyase Inhibition Increases Glycolysis in Adult Cardiomyocytes and Restores Glycolytic Flux in Diabetic CardiomyopathyJens Vogt, Melissa Kim Nowak, Marcel Benkhoff, et al.Blood Advances|September 3, 2024
Thromboinflammation is associated with clinical outcome after ST-elevation myocardial infarctionMarcel Benkhoff, Karin Alde, Vincent Ehreiser, et al.Cells|November 11, 2022
Only Acute but Not Chronic Thrombocytopenia Protects Mice against Left Ventricular Dysfunction after Acute Myocardial InfarctionFriedrich Reusswig, Amin Polzin, Meike Klier, et al.Thrombosis and Haemostasis|December 4, 2025
Free Fatty Acids Link Residual Lipid and Thrombotic Risk via Impairment of Aspirin Antiplatelet EffectsPhilipp Mourikis, Saif Zako, Carolin Helten, et al.Diabetes, Obesity & Metabolism|December 29, 2025
Defective high-density lipoprotein lipoprotection in type 2 diabetes during acute myocardial infarction is rescued by apolipoprotein M/sphingosine-1-phosphate loadingJens Vogt, Marcel Benkhoff, Nathalie H Schröder, et al.Deutsche Medizinische Wochenschrift (1946)|July 31, 2018
[Update ESC-Guideline 2017: Dual Antiplatelet Therapy]Steffen Massberg, Amin PolzinBiomedicines|October 26, 2024
Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial InfarctionAlexander Lang, Daniel Oehler, Marcel Benkhoff, et al.International Journal of Cardiology. Heart & Vasculature|March 25, 2021
Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCILisa Dannenberg, Shazia Afzal, Natalia Czychy, et al.Pageof 19